Literature DB >> 28595316

Developing a local antimicrobial resistance action plan: the Cornwall One Health Antimicrobial Resistance Group.

Neil Powell1,2, Iain Davidson3, Phillip Yelling4, Andrew Collinson5, Adam Pollard6, Lisa Johnson7, Nick Gibson7, Jennifer Taylor8, Kathryn Wisner7, William Gaze9, Janice South10, Diane Ashiru-Oredope11.   

Abstract

Objectives: The UK Five Year Antimicrobial Resistance (AMR) Strategy was published in September 2013 and recommended a One Health approach emphasizing the importance of collaboration to tackle AMR. We describe the inauguration of what we believe to be the first regional One Health group established in the UK. The purpose of the group was to ensure the implementation of a coordinated Cornwall-wide response to the UK AMR Strategy and we describe the outputs of the group to date.
Methods: The Cornwall Antimicrobial Resistance Group was set up as a sub-group of the Health & Wellbeing Board's Health Protection Committee. Stakeholders reviewed the key objectives set out within the Five Year AMR strategy, identified local priorities and existing work streams within Cornwall, and completed a gap analysis. The annual work plan was developed from the gap analysis and provided a foundation for improved coordination of One Health antimicrobial stewardship (AMS) activity in Cornwall.
Results: To date, outputs from the group can be arranged under the following themes: education and engagement with the public; education and engagement with healthcare workers and veterinarians; and a comprehensive AMS programme for all sectors. The group continues to grow in size with wider stakeholder engagement and increased variety of work streams. Conclusions: This unique group facilitates discussions across sectors, which has enabled the sharing of knowledge, ideas and resources, stimulated local AMS initiatives, and ensured a platform for the development of future AMR and AMS work.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28595316      PMCID: PMC5890714          DOI: 10.1093/jac/dkx164

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Antibiotic prescribing is higher in deprived areas of England.

Authors:  Jacqui Wise
Journal:  BMJ       Date:  2015-11-12

Review 2.  Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme.

Authors:  S Mölstad; M Erntell; H Hanberger; E Melander; C Norman; G Skoog; C Stålsby Lundborg; A Söderström; E Torell; O Cars
Journal:  Lancet Infect Dis       Date:  2008-02       Impact factor: 25.071

3.  A process evaluation of the UK-wide Antibiotic Guardian campaign: developing engagement on antimicrobial resistance.

Authors:  Alex Bhattacharya; Susan Hopkins; Anna Sallis; Emma L Budd; Diane Ashiru-Oredope
Journal:  J Public Health (Oxf)       Date:  2017-06-01       Impact factor: 2.341

  3 in total
  9 in total

Review 1.  An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance.

Authors:  Md Mominur Rahman; Mst Afroza Alam Tumpa; Mehrukh Zehravi; Md Taslim Sarker; Md Yamin; Md Rezaul Islam; Md Harun-Or-Rashid; Muniruddin Ahmed; Sarker Ramproshad; Banani Mondal; Abhijit Dey; Fouad Damiri; Mohammed Berrada; Md Habibur Rahman; Simona Cavalu
Journal:  Antibiotics (Basel)       Date:  2022-05-16

Review 2.  A whole-health-economy approach to antimicrobial stewardship: Analysis of current models and future direction.

Authors:  Monsey McLeod; Raheelah Ahmad; Nada Atef Shebl; Christianne Micallef; Fiona Sim; Alison Holmes
Journal:  PLoS Med       Date:  2019-03-29       Impact factor: 11.069

3.  Prevalence and Molecular Epidemiology of Extended-Spectrum-β-Lactamase (ESBL)-Producing Escherichia coli From Multiple Sectors of the Swine Industry in Korea: A Korean Nationwide Monitoring Program for a One Health Approach to Combat Antimicrobial Resistance.

Authors:  Young Ah Kim; Hyunsoo Kim; Young Hee Seo; Go Eun Park; Hyukmin Lee; Kyungwon Lee
Journal:  Ann Lab Med       Date:  2021-05-01       Impact factor: 3.464

4.  Examining the Effect of Context, Beliefs, and Values on UK Farm Veterinarians' Antimicrobial Prescribing: A Randomized Experimental Vignette and Cross-Sectional Survey.

Authors:  Sarah E Golding; Jane Ogden; Helen M Higgins
Journal:  Antibiotics (Basel)       Date:  2021-04-15

Review 5.  Emerging antimicrobial resistance and need for antimicrobial stewardship for ocular infections in India: A narrative review.

Authors:  Partha Biswas; Sneha Batra; Neha Gurha; Nitin Maksane
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

6.  A UK hospital survey to explore healthcare professional views and attitudes to patients incorrectly labelled as penicillin allergic: an antibiotic stewardship patient safety project.

Authors:  Michael Wilcock; Neil Powell; Jonathan Sandoe
Journal:  Eur J Hosp Pharm       Date:  2018-05-24

7.  Assessing the Knowledge, Attitudes and Behaviors of Human and Animal Health Students towards Antibiotic Use and Resistance: A Pilot Cross-Sectional Study in the UK.

Authors:  Oliver James Dyar; Holly Hills; Lara-Turiya Seitz; Alex Perry; Diane Ashiru-Oredope
Journal:  Antibiotics (Basel)       Date:  2018-01-30

8.  Environmental observation, social media, and One Health action: A description of the Local Environmental Observer (LEO) Network.

Authors:  Emily Mosites; Erica Lujan; Michael Brook; Michael Brubaker; Desirae Roehl; Moses Tcheripanoff; Thomas Hennessy
Journal:  One Health       Date:  2018-10-11

9.  Whole-Genome Analysis of blaCTX-M-55-Carrying Escherichia coli Among Pigs, Farm Environment, and Farm Workers.

Authors:  Young Ah Kim; Hyunsoo Kim; Min Hyuk Choi; Young Hee Seo; Hyukmin Lee; Kyungwon Lee
Journal:  Ann Lab Med       Date:  2020-03       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.